Invention Grant
- Patent Title: Modulation of eIF4E-BP2 expression
- Patent Title (中): 调节eIF4E-BP2表达
-
Application No.: US12094598Application Date: 2006-11-21
-
Publication No.: US07807652B2Publication Date: 2010-10-05
- Inventor: Sanjay Bhanot , Kenneth W. Dobie , Ravi Jain
- Applicant: Sanjay Bhanot , Kenneth W. Dobie , Ravi Jain
- Applicant Address: US CA Carlsbad
- Assignee: Isis Pharmaceuticals, Inc.
- Current Assignee: Isis Pharmaceuticals, Inc.
- Current Assignee Address: US CA Carlsbad
- Agency: McDermott Will & Emery
- International Application: PCT/US2006/061175 WO 20061121
- International Announcement: WO2007/062380 WO 20070531
- Main IPC: A61K31/70
- IPC: A61K31/70 ; C07H21/02 ; C07H21/04 ; C12Q1/68
Abstract:
Compounds, compositions and methods are provided for modulating the expression of eIF4E-BP2. The compositions comprise oligonucleotides, targeted to nucleic acid encoding eIF4E-BP2. Methods of using these compounds for modulation of eIF4E-BP2 expression and for diagnosis and treatment of diseases and conditions associated with expression of eIF4E-BP2 are provided.
Public/Granted literature
- US20090203765A1 MODULATION OF EIF4E-BP2 EXPRESSION Public/Granted day:2009-08-13
Information query
